Disciplined Growth Investors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-30,918
Closed -$343K 68
2024
Q3
$343K Sell
30,918
-22,852
-42% -$253K 0.01% 64
2024
Q2
$499K Buy
53,770
+3,352
+7% +$31.1K 0.01% 61
2024
Q1
$1.65M Buy
50,418
+82
+0.2% +$2.69K 0.03% 63
2023
Q4
$1.35M Buy
50,336
+1,103
+2% +$29.5K 0.03% 61
2023
Q3
$2.98M Buy
49,233
+227
+0.5% +$13.7K 0.07% 58
2023
Q2
$4.99M Buy
49,006
+884
+2% +$90.1K 0.11% 55
2023
Q1
$8.51M Buy
48,122
+276
+0.6% +$48.8K 0.22% 51
2022
Q4
$18.5M Buy
47,846
+617
+1% +$239K 0.47% 41
2022
Q3
$15.9M Buy
47,229
+39
+0.1% +$13.1K 0.44% 45
2022
Q2
$15.5M Buy
47,190
+125
+0.3% +$41.1K 0.42% 48
2022
Q1
$20.6M Buy
47,065
+1,041
+2% +$455K 0.45% 48
2021
Q4
$20.2M Sell
46,024
-340
-0.7% -$149K 0.41% 49
2021
Q3
$25.8M Buy
46,364
+27,618
+147% +$15.4M 0.51% 49
2021
Q2
$9.63M Buy
18,746
+2,260
+14% +$1.16M 0.18% 62
2021
Q1
$12.9M Sell
16,486
-2,678
-14% -$2.09M 0.26% 56
2020
Q4
$10.4M Sell
19,164
-1,207
-6% -$657K 0.2% 60
2020
Q3
$9.33M Buy
20,371
+28
+0.1% +$12.8K 0.22% 59
2020
Q2
$12.5M Sell
20,343
-672
-3% -$414K 0.3% 58
2020
Q1
$9.99M Sell
21,015
-2,288
-10% -$1.09M 0.23% 58
2019
Q4
$13.5M Buy
23,303
+1
+0% +$580 0.22% 60
2019
Q3
$15.3M Buy
23,302
+16
+0.1% +$10.5K 0.28% 57
2019
Q2
$18M Sell
23,286
-405
-2% -$313K 0.34% 53
2019
Q1
$16.7M Buy
23,691
+153
+0.7% +$108K 0.29% 53
2018
Q4
$11M Sell
23,538
-64
-0.3% -$30K 0.23% 62
2018
Q3
$20.4M Sell
23,602
-239
-1% -$206K 0.34% 52
2018
Q2
$16.4M Sell
23,841
-36
-0.2% -$24.8K 0.3% 55
2018
Q1
$10.6M Sell
23,877
-46
-0.2% -$20.5K 0.21% 60
2017
Q4
$10.5M Buy
23,923
+335
+1% +$148K 0.21% 61
2017
Q3
$11.6M Sell
23,588
-747
-3% -$368K 0.24% 59
2017
Q2
$13.5M Sell
24,335
-14
-0.1% -$7.76K 0.28% 57
2017
Q1
$16.1M Sell
24,349
-321
-1% -$213K 0.36% 57
2016
Q4
$8.25M Buy
+24,670
New +$8.25M 0.19% 62